957 related articles for article (PubMed ID: 32423886)
1. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
Tang H; Wang Z; Shao Q; Wang Y; Yang Q
Med Sci Monit; 2020 Jun; 26():e922676. PubMed ID: 32533823
[TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
[TBL] [Abstract][Full Text] [Related]
7. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
8. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
10. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
13. Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
Zhao W; Wang J; Luo Q; Peng W; Li B; Wang L; Zhang C; Duan C
BMC Med Genomics; 2020 Dec; 13(1):185. PubMed ID: 33308216
[TBL] [Abstract][Full Text] [Related]
14. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
15. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
16. Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma.
Jin D; Song Y; Chen Y; Zhang P
Biomed Res Int; 2020; 2020():7573689. PubMed ID: 32149133
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
19. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
20. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
